References
- Azoulay L, Blais L, Koren G, LeLorier J, Bérard A. 2008. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry 69:526–532.
- Barak Y, Wohl W, Greenberg Y, Bar Dayan Y, Friedman T, Shoval G, . 2005. Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol 20:39–41.
- Bremner JD, McCaffery P. 2008. The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry 32:315–31.
- Goodman AB. 1998. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 95:7240–7244.
- Hull PR, D'Arcy C. 2003. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 4:493–505.
- Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN. 2009. Isotretinoin and psychopathology: a review. Ann Gen Psychiatry 8:2.
- Mann K, Rothschild JM, Keohane CA, Chu JA, Bates DW. 2008. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification. World J Biol Psychiatry 9:24–33.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, . 1981. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245.
- Ng CH, Tam MM, Hook SJ. 2001. Acne, isotretinoin treatment and acute depression. World J Biol Psychiatry 2:159–161.
- Strahan JE, Raimer S. 2006. Isotretinoin and the controversy of psychiatric adverse effects. Int J Dermatol 45:789–799.